Cargando…

Host-Directed Therapies for Cutaneous Leishmaniasis

Cutaneous leishmaniasis exhibits a wide spectrum of clinical presentations from self-resolving infections to severe chronic disease. Anti-parasitic drugs are often ineffective in the most severe forms of the disease, and in some cases the magnitude of the disease can result from an uncontrolled infl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Novais, Fernanda O., Amorim, Camila Farias, Scott, Phillip
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032888/ https://www.ncbi.nlm.nih.gov/pubmed/33841444 http://dx.doi.org/10.3389/fimmu.2021.660183

Ejemplares similares

Localized skin inflammation during cutaneous leishmaniasis drives a chronic, systemic IFN-γ signature
por: Farias Amorim, Camila, et al.
Publicado: (2021)

NKG2D promotes CD8 T cell-mediated cytotoxicity and is associated with treatment failure in human cutaneous leishmaniasis
por: Sacramento, Laís A., et al.
Publicado: (2023)

Immune Checkpoint Targets for Host-Directed Therapy to Prevent and Treat Leishmaniasis
por: Kumar, Rajiv, et al.
Publicado: (2017)

Cytotoxic T Cells Mediate Pathology and Metastasis in Cutaneous Leishmaniasis
por: Novais, Fernanda O., et al.
Publicado: (2013)

Topical Simvastatin as Host-Directed Therapy against Severity of Cutaneous Leishmaniasis in Mice
por: Parihar, Suraj P., et al.
Publicado: (2016)

Protective Immunity and Vaccination Against Cutaneous Leishmaniasis
por: Okwor, Ifeoma, et al.
Publicado: (2012)

Cutaneous Leishmaniasis Vaccination: A Matter of Quality
por: De Luca, Paula Mello, et al.
Publicado: (2016)

Matrix Metalloproteinase 9 Production by Monocytes is Enhanced by TNF and Participates in the Pathology of Human Cutaneous Leishmaniasis
por: Campos, Taís M., et al.
Publicado: (2014)

Purinergic Cooperation Between P2Y(2) and P2X7 Receptors Promote Cutaneous Leishmaniasis Control: Involvement of Pannexin-1 and Leukotrienes
por: Thorstenberg, Maria Luiza, et al.
Publicado: (2018)

Coinfection With Trypanosoma brucei Confers Protection Against Cutaneous Leishmaniasis
por: Pereira, Lais, et al.
Publicado: (2018)

Opinion Article: NK Cells in Cutaneous Leishmaniasis: Protection or Damage?
por: Cavalcante, Marton Kaique de Andrade, et al.
Publicado: (2022)

Distinct plasma chemokines and cytokines signatures in Leishmania guyanensis-infected patients with cutaneous leishmaniasis
por: de Mesquita, Tirza Gabrielle Ramos, et al.
Publicado: (2022)

PD-1 Blockade Modulates Functional Activities of Exhausted-Like T Cell in Patients With Cutaneous Leishmaniasis
por: Garcia de Moura, Renan, et al.
Publicado: (2021)

Imaging of the host/parasite interplay in cutaneous leishmaniasis
por: Millington, Owain R., et al.
Publicado: (2010)

Clinical and immunological spectra of human cutaneous leishmaniasis in North Africa and French Guiana
por: Saidi, Nasreddine, et al.
Publicado: (2023)

Host-Directed Therapy in Tuberculosis: Targeting Host Metabolism
por: Kim, Jae-Sung, et al.
Publicado: (2020)

Circulating Senescent T Cells Are Linked to Systemic Inflammation and Lesion Size During Human Cutaneous Leishmaniasis
por: Covre, Luciana P., et al.
Publicado: (2019)

Protective Cellular Immune Response Induction for Cutaneous Leishmaniasis by a New Immunochemotherapy Schedule
por: da Silva, Danielle A. M., et al.
Publicado: (2020)

Identification of Immunodominant Antigens From a First-Generation Vaccine Against Cutaneous Leishmaniasis
por: Germanó, María José, et al.
Publicado: (2022)

Effects of Bone Marrow Mesenchymal Stromal Cell Therapy in Experimental Cutaneous Leishmaniasis in BALB/c Mice Induced by Leishmania amazonensis
por: Pereira, Joyce Carvalho, et al.
Publicado: (2017)

Inhibition of gamma-secretase activity without interfering in Notch signalling decreases inflammatory response in patients with cutaneous leishmaniasis
por: Nascimento, Maurício T., et al.
Publicado: (2021)

Immunoproteomics and phage display in the context of leishmaniasis complexity
por: Ludolf, Fernanda, et al.
Publicado: (2023)

Blockade of TLR2 and TLR4 Attenuates Inflammatory Response and Parasite Load in Cutaneous Leishmaniasis
por: Carneiro, Pedro Paulo, et al.
Publicado: (2021)

Interleukin-4 Receptor Alpha: From Innate to Adaptive Immunity in Murine Models of Cutaneous Leishmaniasis
por: Hurdayal, Ramona, et al.
Publicado: (2017)

Morphoproteomic-Guided Host-Directed Therapy for Tuberculosis
por: Brown, Robert E., et al.
Publicado: (2017)

Granulomas and Inflammation: Host-Directed Therapies for Tuberculosis
por: Ndlovu, Hlumani, et al.
Publicado: (2016)

Cutaneous Leishmaniasis presenting as an exuberant forehead lesion
por: Paul, Ingrid Reuwsaat, et al.
Publicado: (2023)

Cutaneous leishmaniasis mimicking cutaneous lymphoma
por: Pires, Carla Andréa Avelar, et al.
Publicado: (2019)

In Vitro Immunomodulatory Activity of a Transition-State Analog Inhibitor of Human Purine Nucleoside Phosphorylase in Cutaneous Leishmaniasis
por: Carvalho, Natália Barbosa, et al.
Publicado: (2017)

FasL and TRAIL signaling in the skin during cutaneous leishmaniasis - implications for tissue immunopathology and infectious control
por: Rethi, Bence, et al.
Publicado: (2012)

Host-Pathogen Interaction as a Novel Target for Host-Directed Therapies in Tuberculosis
por: Abreu, Rodrigo, et al.
Publicado: (2020)

CCR5 promotes the migration of CD8(+) T cells to the leishmanial lesions
por: Sacramento, Laís Amorim, et al.
Publicado: (2023)

A fine mapping of single nucleotide variants and haplotype analysis of IL13 gene in patients with Leishmania guyanensis-cutaneous leishmaniasis and plasma cytokines IL-4, IL-5, and IL-13
por: Junior, José do Espírito Santo, et al.
Publicado: (2023)

Host-Directed Therapies: Modulating Inflammation to Treat Tuberculosis
por: Krug, Stefanie, et al.
Publicado: (2021)

Ecology of cutaneous leishmaniasis in Sinai: linking parasites, vectors and hosts
por: Samy, Abdallah Mohammed, et al.
Publicado: (2014)

Microbiota instruct IL-17A-producing innate lymphoid cells to promote skin inflammation in cutaneous leishmaniasis
por: Singh, Tej Pratap, et al.
Publicado: (2021)

Peptide Vaccines for Leishmaniasis
por: De Brito, Rory C. F., et al.
Publicado: (2018)

Unraveling the Mechanisms of Cutaneous Graft-Versus-Host Disease
por: Santos e Sousa, Pedro, et al.
Publicado: (2018)

The New Frontier of Host-Directed Therapies for Mycobacterium avium Complex
por: Crilly, Nathan P., et al.
Publicado: (2021)

Host Directed Therapy Against Infection by Boosting Innate Immunity
por: Bergman, Peter, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2vejoa7ckl4prkacon0fnf8eo0